LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $748 | -2.0% | 226,714 | -1.9% | 0.00% | 0.0% |
| Q2 2023 | $763 | +0.3% | 231,159 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $761 | -9.6% | 229,914 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $842 | -100.0% | 233,114 | -6.9% | 0.00% | -66.7% |
| Q3 2022 | $2,217,000 | +6.6% | 250,513 | -7.3% | 0.00% | +50.0% |
| Q2 2022 | $2,080,000 | -18.6% | 270,112 | -0.6% | 0.00% | -33.3% |
| Q1 2022 | $2,554,000 | +33.0% | 271,712 | -1.9% | 0.00% | +50.0% |
| Q4 2021 | $1,920,000 | -29.5% | 277,112 | -3.2% | 0.00% | -50.0% |
| Q3 2021 | $2,724,000 | -10.9% | 286,412 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $3,058,000 | -21.4% | 305,757 | -8.0% | 0.00% | -20.0% |
| Q1 2021 | $3,889,000 | -64.7% | 332,419 | +7.6% | 0.01% | -58.3% |
| Q4 2020 | $11,028,000 | +160.7% | 308,812 | +0.9% | 0.01% | +200.0% |
| Q3 2020 | $4,230,000 | -17.0% | 306,112 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $5,099,000 | +91.6% | 309,191 | -1.2% | 0.00% | +33.3% |
| Q1 2020 | $2,661,000 | – | 313,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $6,714,000 | 1.63% |
| Investors Financial Group, LLC | 115,260 | $1,901,000 | 1.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,169 | $15,437,000 | 0.45% |
| NEA Management Company, LLC | 526,663 | $8,685,000 | 0.35% |
| Logos Global Management LP | 50,000 | $825,000 | 0.16% |
| Wealth Advisors of Iowa, LLC | 11,760 | $194,000 | 0.15% |
| Blackstone Inc. | 468,145 | $7,720,000 | 0.03% |
| Jefferies Group LLC | 120,651 | $1,990,000 | 0.02% |
| Texas Yale Capital Corp. | 15,000 | $247,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,043 | $199,000 | 0.00% |